-
1
-
-
84901710470
-
Screening for lung cancer using low dose computed tomography
-
Tammemagi MC, Lam S. Screening for lung cancer using low dose computed tomography. BMJ. 2014;348:g2253.
-
(2014)
BMJ
, vol.348
, pp. g2253
-
-
Tammemagi, M.C.1
Lam, S.2
-
3
-
-
33947502512
-
Lung cancer in never smokers: A review
-
Subramanian J, Govindan R. Lung cancer in never smokers: a review. J Clin Oncol. 2007;25:561-570.
-
(2007)
J Clin Oncol
, vol.25
, pp. 561-570
-
-
Subramanian, J.1
Govindan, R.2
-
4
-
-
84885353689
-
Early and locally advanced non-small-cell lung cancer (nsclc): Esmo clinical practice guidelines for diagnosis, treatment and follow-up
-
Vansteenkiste J, De Ruysscher D, Eberhardt WE, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(suppl 6):vi89-vi98.
-
(2013)
Ann Oncol
, vol.24
, pp. vi89-vi98
-
-
Vansteenkiste, J.1
De Ruysscher, D.2
Eberhardt, W.E.3
-
5
-
-
84904762009
-
Adjuvant or neoadjuvant chemotherapy for nsclc
-
McElnay P, Lim E. Adjuvant or neoadjuvant chemotherapy for NSCLC. J Thorac Dis. 2014;6:S224-S227.
-
(2014)
J Thorac Dis
, vol.6
, pp. S224-S227
-
-
McElnay, P.1
Lim, E.2
-
6
-
-
33745192066
-
Patterns of failure after resection of nonsmall-cell lung cancer: Implications for postoperative radiation therapy volumes
-
Kelsey CR, Light KL, Marks LB, et al. Patterns of failure after resection of nonsmall-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys. 2006;65:1097-1105.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, pp. 1097-1105
-
-
Kelsey, C.R.1
Light, K.L.2
Marks, L.B.3
-
7
-
-
0030912190
-
Revisions in the international system for staging lung cancer
-
Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
-
(1997)
Chest
, vol.111
, pp. 1710-1717
-
-
Mountain, C.F.1
-
8
-
-
0033994195
-
Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage i, ii, and iiia
-
van Rens MT, de la Riviere AB, Elbers HR, et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117:374-379.
-
(2000)
Chest
, vol.117
, pp. 374-379
-
-
Van Rens, M.T.1
De La Riviere, A.B.2
Elbers, H.R.3
-
9
-
-
1842830208
-
Tnm classification for lung cancer
-
Watanabe Y. TNM classification for lung cancer. Ann Thorac Cardiovasc Surg. 2003;9:343-350.
-
(2003)
Ann Thorac Cardiovasc Surg
, vol.9
, pp. 343-350
-
-
Watanabe, Y.1
-
10
-
-
0037313062
-
Improved prognostic value of 18f-fdg pet using a simple visual analysis of tumor characteristics in patients with cervical cancer
-
Miller TR, Pinkus E, Dehdashti F, et al. Improved prognostic value of 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. J Nucl Med. 2003;44:192-197.
-
(2003)
J Nucl Med
, vol.44
, pp. 192-197
-
-
Miller, T.R.1
Pinkus, E.2
Dehdashti, F.3
-
11
-
-
0036326395
-
Prognostic significance of 18f-fdg and 99mtc-methylene diphosphonate uptake in primary osteosarcoma
-
Franzius C, Bielack S, Flege S, et al. Prognostic significance of 18F-FDG and 99mTc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med. 2002;43:1012-1017.
-
(2002)
J Nucl Med
, vol.43
, pp. 1012-1017
-
-
Franzius, C.1
Bielack, S.2
Flege, S.3
-
12
-
-
84881433120
-
18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: A 15-year institutional experience
-
Siva S, Byrne K, Seel M, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in the staging of Merkel cell carcinoma: a 15-year institutional experience. J Nucl Med. 2013;54:1223-1229.
-
(2013)
J Nucl Med
, vol.54
, pp. 1223-1229
-
-
Siva, S.1
Byrne, K.2
Seel, M.3
-
13
-
-
0034721257
-
Preoperative staging of nonsmall-cell lung cancer with positron-emission tomography
-
Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of nonsmall-cell lung cancer with positron-emission tomography. N Engl J Med. 2000;343:254-261.
-
(2000)
N Engl J Med
, vol.343
, pp. 254-261
-
-
Pieterman, R.M.1
Van Putten, J.W.2
Meuzelaar, J.J.3
-
14
-
-
84904115991
-
Follow-up or surveillance 18f-fdg pet/ct and survival outcome in lung cancer patients
-
Antoniou AJ, Marcus C, Tahari AK, et al. Follow-up or surveillance 18F-FDG PET/CT and survival outcome in lung cancer patients. J Nucl Med. 2014;55:1062-1068.
-
(2014)
J Nucl Med
, vol.55
, pp. 1062-1068
-
-
Antoniou, A.J.1
Marcus, C.2
Tahari, A.K.3
-
15
-
-
70350743151
-
18F-FDG uptake in lung, breast, and colon cancers: Molecular biology correlates and disease characterization
-
Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med. 2009;50:1820-1827.
-
(2009)
J Nucl Med
, vol.50
, pp. 1820-1827
-
-
Jadvar, H.1
Alavi, A.2
Gambhir, S.S.3
-
16
-
-
0036171903
-
Relationship between retention index in dual-phase 18f-fdg pet, and hexokinase-ii and glucose transporter-1 expression in pancreatic cancer
-
Higashi T, Saga T, Nakamoto Y, et al. Relationship between retention index in dual-phase 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med. 2002;43:173-180.
-
(2002)
J Nucl Med
, vol.43
, pp. 173-180
-
-
Higashi, T.1
Saga, T.2
Nakamoto, Y.3
-
17
-
-
12444279265
-
On the origin of cancer cells
-
Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
-
(1956)
Science
, vol.123
, pp. 309-314
-
-
Warburg, O.1
-
18
-
-
8144228566
-
Why do cancers have high aerobic glycolysis?
-
Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891-899.
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 891-899
-
-
Gatenby, R.A.1
Gillies, R.J.2
-
19
-
-
84888433384
-
Lactate dehydrogenase a in cancer: A promising target for diagnosis and therapy
-
Miao P, Sheng S, Sun X, et al. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013;65:904-910.
-
(2013)
IUBMB Life
, vol.65
, pp. 904-910
-
-
Miao, P.1
Sheng, S.2
Sun, X.3
-
20
-
-
33744783432
-
Attenuation of ldh-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
-
Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425-434.
-
(2006)
Cancer Cell
, vol.9
, pp. 425-434
-
-
Fantin, V.R.1
St-Pierre, J.2
Leder, P.3
-
21
-
-
84867097473
-
Knockdown of lactate dehydrogenase a suppresses tumor growth and metastasis of human hepatocellular carcinoma
-
Sheng SL, Liu JJ, Dai YH, et al. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J. 2012;279:3898-3910.
-
(2012)
FEBS J
, vol.279
, pp. 3898-3910
-
-
Sheng, S.L.1
Liu, J.J.2
Dai, Y.H.3
-
22
-
-
76649126249
-
Inhibition of lactate dehydrogenase a induces oxidative stress and inhibits tumor progression
-
Le A, Cooper CR, Gouw AM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 2010;107:2037-2042.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2037-2042
-
-
Le Cooper A, C.R.1
Gouw, A.M.2
-
23
-
-
84898609171
-
Using a yeast two-hybrid system to identify ftcd as a new regulator for hif-1alpha in hepg2 cells
-
Yu Z, Ge Y, Xie L, et al. Using a yeast two-hybrid system to identify FTCD as a new regulator for HIF-1alpha in HepG2 cells. Cell Signal. 2014;26:1560-1566.
-
(2014)
Cell Signal
, vol.26
, pp. 1560-1566
-
-
Yu, Z.1
Ge, Y.2
Xie, L.3
-
24
-
-
84870598190
-
Erk1/2-dependent phosphorylation and nuclear translocation of pkm2 promotes thewarburg effect
-
Yang W, Zheng Y, Xia Y, et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes theWarburg effect. Nat Cell Biol. 2012;14:1295-1304.
-
(2012)
Nat Cell Biol
, vol.14
, pp. 1295-1304
-
-
Yang, W.1
Zheng, Y.2
Xia, Y.3
-
25
-
-
60549111398
-
Is akt the "warburg kinase"? Akt-energy metabolism interactions and oncogenesis
-
Robey RB, Hay N. Is Akt the "Warburg kinase"?: Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol. 2009;19:25-31.
-
(2009)
Semin Cancer Biol
, vol.19
, pp. 25-31
-
-
Robey, R.B.1
Hay, N.2
-
26
-
-
84861552793
-
The skp2-scf e3 ligase regulates akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis
-
Chan CH, Li CF, Yang WL, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell. 2012;149:1098-1111.
-
(2012)
Cell
, vol.149
, pp. 1098-1111
-
-
Chan, C.H.1
Li, C.F.2
Yang, W.L.3
-
27
-
-
42049121240
-
Warburg revisited: Imaging tumour blood flow and metabolism
-
Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging. 2008;8:81-86.
-
(2008)
Cancer Imaging
, vol.8
, pp. 81-86
-
-
Miles, K.A.1
Williams, R.E.2
-
28
-
-
0036077547
-
Glucose transporters: Expression, regulation and cancer
-
Medina RA, Owen GI. Glucose transporters: expression, regulation and cancer. Biol Res. 2002;35:9-26.
-
(2002)
Biol Res
, vol.35
, pp. 9-26
-
-
Medina, R.A.1
Owen, G.I.2
-
29
-
-
12944262229
-
Molecular and cellular regulation of glucose transporter (glut) proteins in cancer
-
Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654-662.
-
(2005)
J Cell Physiol
, vol.202
, pp. 654-662
-
-
Macheda, M.L.1
Rogers, S.2
Best, J.D.3
-
30
-
-
0034983918
-
Inhibition of early apoptotic events by akt/pkb is dependent on the first committed step of glycolysis and mitochondrial hexokinase
-
Gottlob K, Majewski N, Kennedy S, et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15:1406-1418.
-
(2001)
Genes Dev
, vol.15
, pp. 1406-1418
-
-
Gottlob, K.1
Majewski, N.2
Kennedy, S.3
-
31
-
-
79951699777
-
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
-
Wolf A, Agnihotri S, Micallef J, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208:313-326.
-
(2011)
J Exp Med
, vol.208
, pp. 313-326
-
-
Wolf, A.1
Agnihotri, S.2
Micallef, J.3
-
32
-
-
70349484491
-
Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis
-
Palmieri D, Fitzgerald D, Shreeve SM, et al. Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res. 2009;7:1438-1445.
-
(2009)
Mol Cancer Res
, vol.7
, pp. 1438-1445
-
-
Palmieri, D.1
Fitzgerald, D.2
Shreeve, S.M.3
-
33
-
-
84858162402
-
Relationship between 18f-fluorodeoxyglucose accumulation and kras/braf mutations in colorectal cancer
-
Kawada K, Nakamoto Y, Kawada M, et al. Relationship between 18F-fluorodeoxyglucose accumulation and KRAS/BRAF mutations in colorectal cancer. Clin Cancer Res. 2012;18:1696-1703.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 1696-1703
-
-
Kawada, K.1
Nakamoto, Y.2
Kawada, M.3
-
34
-
-
0030921103
-
C-myc transactivation of ldh-A: Implications for tumor metabolism and growth
-
Shim H, Dolde C, Lewis BC, et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci USA. 1997;94:6658-6663.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 6658-6663
-
-
Shim, H.1
Dolde, C.2
Lewis, B.C.3
|